Cargando…
Immune checkpoint alterations and their blockade in COVID-19 patients
Coronavirus disease 2019 (COVID-19) is a highly contagious disease that seriously affects people’s lives. Immune dysfunction, which is characterized by abnormal expression of multiple immune checkpoint proteins (ICs) on immune cells, is associated with progression and poor prognosis for tumors and c...
Autores principales: | Tan, Jiaxiong, Li, Yangqiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592141/ https://www.ncbi.nlm.nih.gov/pubmed/36311817 http://dx.doi.org/10.1097/BS9.0000000000000132 |
Ejemplares similares
-
Immune checkpoint inhibitors in cancer patients with COVID-19
por: Pan, Yun, et al.
Publicado: (2023) -
Immune checkpoint blockade in HIV
por: Gubser, Celine, et al.
Publicado: (2022) -
Immune-Checkpoint Blockade Therapy in Lymphoma
por: Kuzume, Ayumi, et al.
Publicado: (2020) -
Neutrophils in the era of immune checkpoint blockade
por: Faget, Julien, et al.
Publicado: (2021) -
Predictive biomarkers for tumor immune checkpoint blockade
por: Tong, Mengting, et al.
Publicado: (2018)